Rajni Aneja – Humana

As Strategic Executive and Clinical Transformation Leader Dr. Rajni Aneja brings her leadership background in care quality standards and diabetes to transform the care delivery model with insurance giant, Humana. She discusses how Humana’s partnership-based approach is spurring innovation in health IT.

Buy, Sell, Exchange: New Markets for Consumers, Employers, and Providers

Nearly a year after ACA implementation, this session dove into the new ways benefits are being offered to consumers, how employers are buying care directly, and what new technologies are enabling change in direct care provision.

Apixio & Dell: Sponsored Session

Apixio and Dell co-sponsored “Risk Assessment and Care Delivery Optimized Using Big Data Analytics.”  The panel discussed opportunities for providers and payers to leverage large volumes of clinical and financial data to (1) improve patient risk assessment for value-based contracts and population health initiatives; and (2) achieve personalized care through detailed understanding of optimal care pathways for high value healthcare delivery.

thumbnail_2_7c6d5117_7_v1

Rajni Aneja – Humana

As Strategic Executive and Clinical Transformation Leader Dr. Rajni Aneja brings her leadership background in care quality standards and diabetes to transform the care delivery model with insurance giant, Humana. She discusses how Humana’s partnership-based approach is spurring innovation in health IT.

Buy Sell

Buy, Sell, Exchange: New Markets for Consumers, Employers, and Pr ...

Nearly a year after ACA implementation, this session dove into the new ways benefits are being offered to consumers, how employers are buying care directly, and what new technologies are enabling change in direct care provision.

DellPanel

Apixio & Dell: Sponsored Session

Apixio and Dell co-sponsored “Risk Assessment and Care Delivery Optimized Using Big Data Analytics.”  The panel discussed opportunities for providers and payers to leverage large volumes of clinical and financial data to (1) improve patient risk assessment for value-based contracts and population health initiatives; and (2) achieve personalized care through detailed understanding of optimal care pathways for high value healthcare delivery.